MedTrace Logo

Accelerated Partial Breast Irradiation With 3D-CRT and IMRT

NCT02003560 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2014-08-13

No results posted yet for this study

Summary

The purpose of this study is to determine in a phase II clinical trial whether accelerated partial breast irradiation after breast conserving surgery using 3 dimensional external beam radiotherapy (3D-CRT) and intensity modulated radiotherapy (IMRT) for low-risk invasive breast cancer patients is safe without causing serious late radiation side-effects.

Conditions

Interventions

RADIATION

accelerated partial breast irradiation

9 x 4.1 Gy accelerated partial breast irradiation delivered by 3D-CRT or IMRT over 5 consecutive days, using twice-a-day fractionation.

Sponsors & Collaborators

  • National Institute of Oncology, Hungary

    lead OTHER

Principal Investigators

  • Csaba Polgár, MD, PhD, MSc · National Institute of Oncology

  • Norbert Mészáros, MD · National Institute of Oncology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2019-03-31
Completion
2024-03-31

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02003560 on ClinicalTrials.gov